Allergy/Asthma News

Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.

As we enter the second half of 2024, it is important to understand some tax law changes that became effective this year and could affect your retirement savings and tax planning.

Adults treated with amlitelimab showed sustained improvement in their moderate to severe atopic dermatitis over the span of 28 weeks, Sanofi announced in a press release.

SAN DIEGO — Breath profile clusters can predict positive response to anti-IL5 or anti-IL5R alpha asthma treatment 1 month after initiation, according to an abstract presented at the American Thoracic Society International Conference.

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

SAN DIEGO — Pregnant women from an ethnically diverse cohort with a disproportionately higher asthma burden appeared to have high dietary omega-6 and low omega-3, according to study results.

The FDA has cleared InnoCare Pharma’s investigational new drug application for ICP-332, according to a press release.

Patients with chronic spontaneous urticaria experienced early symptom improvements that were sustained through 52 weeks with remibrutinib, according to a presentation at the European Academy of Allergy & Clinical Immunology Congress.

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

There are more than 450 monogenetic immune deficiencies. While many of these rare conditions have similar hallmarks, it is crucial for clinicians to differentiate between them.